{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:47:12Z","timestamp":1740138432701,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Innovation 2030 \u201cNew Generation Artificial Intelligence\u201d Major Project","award":["2020AAA0109600"],"award-info":[{"award-number":["2020AAA0109600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03293-4","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:13:12Z","timestamp":1675782792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-5931","authenticated-orcid":false,"given":"Lin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenglei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yecheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-7086","authenticated-orcid":false,"given":"Xianliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huadong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"3293_CR1","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","volume":"23","author":"R Garcia-Carbonero","year":"2021","unstructured":"R. Garcia-Carbonero, F. Matute Teresa, E. Mercader-Cidoncha et al. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin. Transl. Oncol. 23, 1995\u20132019 (2021). https:\/\/doi.org\/10.1007\/s12094-021-02622-9","journal-title":"Clin. Transl. Oncol."},{"key":"3293_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","volume":"51","author":"AMA Berends","year":"2018","unstructured":"A.M.A. Berends, E. Buitenwerf, R.R. de Krijger et al. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur. J. Intern. Med. 51, 68\u201373 (2018). https:\/\/doi.org\/10.1016\/j.ejim.2018.01.015","journal-title":"Eur. J. Intern. Med."},{"key":"3293_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/s0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"J.W. Lenders, G. Eisenhofer, M. Mannelli et al. Phaeochromocytoma. Lancet 366, 665\u2013675 (2005). https:\/\/doi.org\/10.1016\/s0140-6736(05)67139-5","journal-title":"Lancet"},{"key":"3293_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.amjmed.2008.08.021","volume":"122","author":"R Yu","year":"2009","unstructured":"R. Yu, N.N. Nissen, P. Chopra et al. Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am. J. Med. 122, 85\u201395 (2009). https:\/\/doi.org\/10.1016\/j.amjmed.2008.08.021","journal-title":"Am. J. Med."},{"key":"3293_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3904\/kjim.2018.231","volume":"35","author":"SH Lee","year":"2020","unstructured":"S.H. Lee, J.H. Park, J.Y. Lee et al. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma. Korean J. Intern. Med. 35, 351\u2013359 (2020). https:\/\/doi.org\/10.3904\/kjim.2018.231","journal-title":"Korean J. Intern. Med."},{"key":"3293_CR6","doi-asserted-by":"publisher","unstructured":"A.M.A. Berends, M.N. Kerstens, J.W.M. Lenders et al. Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma. J. Clin. Endocrinol. Metab. 105 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa441","DOI":"10.1210\/clinem\/dgaa441"},{"key":"3293_CR7","doi-asserted-by":"publisher","unstructured":"M. Araujo-Castro, I. Garc\u00eda Sanz, C. M\u00ednguez Ojeda et al. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY. J. Endocrinol. Invest. (2022). https:\/\/doi.org\/10.1007\/s40618-022-01954-9","DOI":"10.1007\/s40618-022-01954-9"},{"key":"3293_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00268-005-7839-4","volume":"29","author":"A Agarwal","year":"2005","unstructured":"A. Agarwal, S. Gupta, A.K. Mishra et al. Normotensive pheochromocytoma: institutional experience. World J. Surg. 29, 1185\u20131188 (2005). https:\/\/doi.org\/10.1007\/s00268-005-7839-4","journal-title":"World J. Surg."},{"key":"3293_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1210\/jcem-49-3-445","volume":"49","author":"JM Feldman","year":"1979","unstructured":"J.M. Feldman, J.A. Blalock, R.T. Zern et al. The relationship between enzyme activity and the catecholamine content and secretion of pheochromocytomas. J. Clin. Endocrinol. Metab. 49, 445\u2013451 (1979). https:\/\/doi.org\/10.1210\/jcem-49-3-445","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3293_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/jci104898","volume":"43","author":"JR Crout","year":"1964","unstructured":"J.R. Crout, A. Sjoerdsma, Turnover and metabolism of catecholamines in patients with pheochromocytoma. J. Clin. Invest. 43, 94\u2013102 (1964). https:\/\/doi.org\/10.1172\/jci104898","journal-title":"J. Clin. Invest."},{"key":"3293_CR11","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/hypertensionaha.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"T. Unger, C. Borghi, F. Charchar et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 75, 1334\u20131357 (2020). https:\/\/doi.org\/10.1161\/hypertensionaha.120.15026","journal-title":"Hypertension"},{"key":"3293_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","volume":"81","author":"A Elenkova","year":"2020","unstructured":"A. Elenkova, J. Matrozova, V. Vasilev et al. Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study. Ann. Endocrinol. 81, 3\u201310 (2020). https:\/\/doi.org\/10.1016\/j.ando.2020.01.001","journal-title":"Ann. Endocrinol."},{"key":"3293_CR13","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1245\/s10434-006-9184-8","volume":"13","author":"D Weismann","year":"2006","unstructured":"D. Weismann, M. Fassnacht, B. Schubert et al. A dangerous liaison\u2013pheochromocytoma in patients with malignant disease. Ann. Surg. Oncol. 13, 1696\u20131701 (2006). https:\/\/doi.org\/10.1245\/s10434-006-9184-8","journal-title":"Ann. Surg. Oncol."},{"key":"3293_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4158\/ep11327.Or","volume":"18","author":"R Yu","year":"2012","unstructured":"R. Yu, N.N. Nissen, S.I. Bannykh, Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors. Endocr. Pr. 18, 483\u2013492 (2012). https:\/\/doi.org\/10.4158\/ep11327.Or","journal-title":"Endocr. Pr."},{"key":"3293_CR15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1751-7176.2009.00182.x","volume":"11","author":"NA Buchbinder","year":"2009","unstructured":"N.A. Buchbinder, R. Yu, B.E. Rosenbloom et al. Left ventricular thrombus and embolic stroke caused by a functional paraganglioma. J. Clin. Hypertens. 11, 734\u2013737 (2009). https:\/\/doi.org\/10.1111\/j.1751-7176.2009.00182.x","journal-title":"J. Clin. Hypertens."},{"key":"3293_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/hypertensionaha.121.17981","volume":"78","author":"G Jia","year":"2021","unstructured":"G. Jia, J.R. Sowers, Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension 78, 1197\u20131205 (2021). https:\/\/doi.org\/10.1161\/hypertensionaha.121.17981","journal-title":"Hypertension"},{"key":"3293_CR17","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.dsx.2020.10.030","volume":"14","author":"S Khatiwada","year":"2020","unstructured":"S. Khatiwada, S. Agarwal, D. Kandasamy et al. Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion\/sensitivity and predictors of remission. Diabetes Metab. Syndr. 14, 2169\u20132175 (2020). https:\/\/doi.org\/10.1016\/j.dsx.2020.10.030","journal-title":"Diabetes Metab. Syndr."},{"key":"3293_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/a-0669-9556","volume":"51","author":"JRU Santos","year":"2019","unstructured":"J.R.U. Santos, A. Brofferio, B. Viana et al. Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease. Horm. Metab. Res. 51, 458\u2013469 (2019). https:\/\/doi.org\/10.1055\/a-0669-9556","journal-title":"Horm. Metab. Res."},{"key":"3293_CR19","first-page":"95","volume":"18","author":"J Axelrod","year":"1966","unstructured":"J. Axelrod, Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharm. Rev. 18, 95\u2013113 (1966)","journal-title":"Pharm. Rev."},{"key":"3293_CR20","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/bph.13458","volume":"173","author":"AJM Verberne","year":"2016","unstructured":"A.J.M. Verberne, W.S. Korim, A. Sabetghadam, I.J. Llewellyn-Smith, Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes. British J Pharmacol 173, 1425\u20131437 (2016). https:\/\/doi.org\/10.1111\/bph.13458","journal-title":"British J Pharmacol"},{"key":"3293_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/ec-17-0321","volume":"7","author":"H Falhammar","year":"2018","unstructured":"H. Falhammar, M. Kjellman, J. Calissendorff, Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center. Endocr. Connect. 7, 186\u2013192 (2018). https:\/\/doi.org\/10.1530\/ec-17-0321","journal-title":"Endocr. Connect."},{"key":"3293_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","volume":"209","author":"MA Guerrero","year":"2009","unstructured":"M.A. Guerrero, J.M. Schreinemakers, M.R. Vriens et al. Clinical spectrum of pheochromocytoma. J. Am. Coll. Surg. 209, 727\u2013732 (2009). https:\/\/doi.org\/10.1016\/j.jamcollsurg.2009.09.022","journal-title":"J. Am. Coll. Surg."},{"key":"3293_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-0032-1306294","volume":"44","author":"T Zelinka","year":"2012","unstructured":"T. Zelinka, O. Petr\u00e1k, H. Turkov\u00e1 et al. High incidence of cardiovascular complications in pheochromocytoma. Horm. Metab. Res. 44, 379\u2013384 (2012). https:\/\/doi.org\/10.1055\/s-0032-1306294","journal-title":"Horm. Metab. Res."},{"key":"3293_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1136\/heartjnl-2013-304073","volume":"99","author":"A Giavarini","year":"2013","unstructured":"A. Giavarini, A. Chedid, G. Bobrie et al. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart 99, 1438\u20131444 (2013). https:\/\/doi.org\/10.1136\/heartjnl-2013-304073","journal-title":"Heart"},{"key":"3293_CR25","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"J.W. Lenders, Q.Y. Duh, G. Eisenhofer et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 1915\u20131942 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03293-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:13:00Z","timestamp":1706199180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03293-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":25,"alternative-id":["3293"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03293-4","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"1 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Peking Union Medical College Hospital (approval number: JS-2898). Owing to the retrospective nature of the study and all data were anonymized before analysis, the requirement for informed consent in this study was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}